Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

French private radiologists strike over planned fee cuts

Private radiologists across France went on strike earlier this week to protest planned cuts to payments for imaging procedures under the draft 2026 Social Security budget. Around 80% of the country’s private radiologists were reported to have joined the strike.

TPG Capital may buy New Zealand’s Tāmaki Health

New Zealand’s largest private primary healthcare provider, Tāmaki Health, is up for sale, and US private equity firm TPG Capital is reported to be close to buying it. The deal, advised by New Zealand multinational investment banking Jarden, is expected to be over NZ$400 (~$224 million USD) and could be completed by Christmas 2025.

The HBI Top 250 largest groups in EMEA by revenue 2025 edition

Introduction Healthcare Business International's inaugural Top 250 ranking tracks revenues of the biggest for-profit healthcare services companies across EMEA, based on analysis of over 4,000 providers. Spanning hospitals, diagnostics, elderly care, dentistry, mental health and outpatient services across Europe, the Middle East and Africa, this year's list reveals some significant market shifts beneath surface stability.  […]

UK’s Practice Plus Group bought by Indian hospital giant Narayana Health

Practice Plus Group (PPG), the UK’s fifth-largest for-profit hospital group by revenue and formerly owned by London private equity firm Bridgepoint, has agreed to sell its hospitals division to Indian healthcare giant Narayana Health for around ~ €215 million.  The deal covers PPG’s secondary care business only, separating it from the group’s Integrated Urgent Care operations, which include NHS 111 contact centres and out-of-hours GP services, and from its Health in Justice division, which provides healthcare within the justice system.

Fremman buys Stingray to merge with Amethyst

Two of Europe’s three largest private oncology groups are being merged into a single entity, creating continental Europe’s largest oncology player. Private equity firm Fremman Capital has acquired Stingray, an oncology group with a presence in France and Germany, to merge it with its portfolio company Amethyst, a major pan-European radiotherapy group which already has a presence in seven European countries.

Find Us